Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386892304> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4386892304 endingPage "796" @default.
- W4386892304 startingPage "792" @default.
- W4386892304 abstract "Epilepsy is a neurological disease that requires long-term drug therapy. Carbamazepine (CBZ) is a drug that is effective in partial seizures, including complex partial seizures, and tonic-clonic seizures. It was aimed to evaluate the effect on serum lipid profile in patients who used CBZ. Medical biochemistry laboratory data between January and December 2021 were analyzed retrospectively. Patients (n=59) who used monotherapy and at least 2 years of CBZ were included in the study. Patients under 18 years of age were not included. In the control group, 34 healthy people with normal blood parameters, who applied to outpatient clinics for different reasons at the same age, and did not have a disease that would affect the lipid profile, were selected. The mean age of the patients was 36 ±8 years. LDL-cholesterol levels were found to be higher in patients treated with carbamazepine compared to the control group (p<0.05). There was no significant difference in serum triglyceride (TG), and HDL-cholesterol levels in the patient and control groups (p>0.05). There was no gender difference in the effect of carbamazepine on LDL-cholesterol (p>0.05). High serum LDL-cholesterol levels cause atherosclerosis and coronary artery disease. The lipid profile of carbamazepine, which is used regularly at the therapeutic level, changes. Due to the association of high LDL-cholesterol levels with atherosclerosis, it is important to monitor lipid levels in patients using CBZ, especially considering the long duration of use of this pharmacotherapy." @default.
- W4386892304 created "2023-09-21" @default.
- W4386892304 creator A5026538652 @default.
- W4386892304 creator A5065127172 @default.
- W4386892304 creator A5081489849 @default.
- W4386892304 date "2023-09-13" @default.
- W4386892304 modified "2023-10-16" @default.
- W4386892304 title "Karbamazepin Kullanan Hastalarda Serum Lipid Düzeylerinin Değerlendirilmesi" @default.
- W4386892304 cites W1961815330 @default.
- W4386892304 cites W1964036912 @default.
- W4386892304 cites W1968675709 @default.
- W4386892304 cites W2087400206 @default.
- W4386892304 cites W2094941678 @default.
- W4386892304 cites W2131278381 @default.
- W4386892304 cites W2135317559 @default.
- W4386892304 cites W2316985586 @default.
- W4386892304 cites W2319151504 @default.
- W4386892304 cites W2953536521 @default.
- W4386892304 cites W3093120097 @default.
- W4386892304 cites W3099354938 @default.
- W4386892304 cites W3105016893 @default.
- W4386892304 cites W3112735504 @default.
- W4386892304 cites W4220799853 @default.
- W4386892304 doi "https://doi.org/10.20515/otd.1346515" @default.
- W4386892304 hasPublicationYear "2023" @default.
- W4386892304 type Work @default.
- W4386892304 citedByCount "0" @default.
- W4386892304 crossrefType "journal-article" @default.
- W4386892304 hasAuthorship W4386892304A5026538652 @default.
- W4386892304 hasAuthorship W4386892304A5065127172 @default.
- W4386892304 hasAuthorship W4386892304A5081489849 @default.
- W4386892304 hasBestOaLocation W43868923042 @default.
- W4386892304 hasConcept C118552586 @default.
- W4386892304 hasConcept C126322002 @default.
- W4386892304 hasConcept C139572402 @default.
- W4386892304 hasConcept C2778163477 @default.
- W4386892304 hasConcept C2778186239 @default.
- W4386892304 hasConcept C2778213512 @default.
- W4386892304 hasConcept C2778270857 @default.
- W4386892304 hasConcept C2778913445 @default.
- W4386892304 hasConcept C2779253243 @default.
- W4386892304 hasConcept C500440147 @default.
- W4386892304 hasConcept C71924100 @default.
- W4386892304 hasConcept C90924648 @default.
- W4386892304 hasConceptScore W4386892304C118552586 @default.
- W4386892304 hasConceptScore W4386892304C126322002 @default.
- W4386892304 hasConceptScore W4386892304C139572402 @default.
- W4386892304 hasConceptScore W4386892304C2778163477 @default.
- W4386892304 hasConceptScore W4386892304C2778186239 @default.
- W4386892304 hasConceptScore W4386892304C2778213512 @default.
- W4386892304 hasConceptScore W4386892304C2778270857 @default.
- W4386892304 hasConceptScore W4386892304C2778913445 @default.
- W4386892304 hasConceptScore W4386892304C2779253243 @default.
- W4386892304 hasConceptScore W4386892304C500440147 @default.
- W4386892304 hasConceptScore W4386892304C71924100 @default.
- W4386892304 hasConceptScore W4386892304C90924648 @default.
- W4386892304 hasIssue "5" @default.
- W4386892304 hasLocation W43868923041 @default.
- W4386892304 hasLocation W43868923042 @default.
- W4386892304 hasOpenAccess W4386892304 @default.
- W4386892304 hasPrimaryLocation W43868923041 @default.
- W4386892304 hasRelatedWork W2049217125 @default.
- W4386892304 hasRelatedWork W2072909849 @default.
- W4386892304 hasRelatedWork W2080734146 @default.
- W4386892304 hasRelatedWork W2125859994 @default.
- W4386892304 hasRelatedWork W2235876034 @default.
- W4386892304 hasRelatedWork W2283060308 @default.
- W4386892304 hasRelatedWork W2412323695 @default.
- W4386892304 hasRelatedWork W2955457204 @default.
- W4386892304 hasRelatedWork W3152358810 @default.
- W4386892304 hasRelatedWork W3187046419 @default.
- W4386892304 hasVolume "45" @default.
- W4386892304 isParatext "false" @default.
- W4386892304 isRetracted "false" @default.
- W4386892304 workType "article" @default.